Publications by authors named "Louis Williams"

Claim this Profile
T
Textbook reading habits and perceptions among PharmD students in an integrated curriculum: A mixed-methods analysis.
Joydip Das, Rudi Safarudin, J Douglas Thornton, Louis Williams

Curr Pharm Teach Learn· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Practice in the Management of Transplant-Eligible Newly Diagnosed Multiple Myeloma: A US-Based Cross-Sectional National Survey.
Hossam M Ali, Zainab Yusufali Motiwala, Yara Shatnawi, Jack Khouri, Faiz Anwer, Louis S Williams

Clin Lymphoma Myeloma Leuk· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists.
Ali Mushtaq, Asfand Yar Cheema, Hossam M Ali, Yara Shatnawi, Omer Ashruf, Louis Williams

Blood Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes.
Daniel Cancilla, Hanny Sawaf, Xuefei Jia, Danai Dima, Ali Mehdi, Louis Williams

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.
Dylan C Gagler, Hussein Ghamlouch, Di Zhang, Patrick Blaney, Avital Tenenbaum, Louis Williams

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis.
David Kaplan, Eric Christian, Jason Valent, Faiz Anwer, Sandra Mazzoni, Louis Williams

J Cell Mol Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibody.
Anam Ashfaque, Yara Shatnawi, Shahzad Raza, Diana Basali, Jack Khouri, Louis Williams

Blood Rev· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma.
Mobina Golmohammadi, Shahzad Raza, Maram Albayyadhi, Hossein Sholehrasa, Jack Khouri, Louis Williams

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Endothelial Activation and Stress Index (EASIX)-based predictive model for cytokine release syndrome and neurotoxicity after B-cell maturation antigen directed chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma.
Utkarsh Goel, Danai Dima, James A Davis, Aliya Rashid, William Wesson, Louis Williams

Bone Marrow Transplant· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viewing of abstract art follows a gist to survey gaze pattern over time regardless of broad categorical titles.
Eugene McSorley, Rachel McCloy, Louis Williams

PLoS One· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signalling Network Analysis of Blood Mononuclear Cells From Clinical Samples by Bivariate Correlation.
David Kaplan, Hillard M Lazarus, Jason Valent, Faiz Anwer, Sandra Mazzoni, Louis Williams

J Cell Mol Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center.
Danai Dima, Utkarsh Goel, Fauzia Ullah, Beth Faiman, Diana Basali, Louis S Williams

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma.
Daniel Cancilla, Daniel Paul Nurse, Wei Wei, Danielle Cenin, Christina Ferraro, Louis Williams

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.
Danai Dima, Michael Hughes, Mark Orland, Fauzia Ullah, Utkarsh Goel, Louis Williams

Amyloid· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma.
Olga Lytvynova, Jenna Jwayyed, Daniel Pastel, Rohan Prasad, Jack Khouri, Louis Williams

Antibodies (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The US Myeloma Immunotherapy Consortium Real- World Experience.
Jack Khouri, Danai Dima, Hong Li, Doris Hansen, Surbhi Sidana, Louis Williams

Transplant Cell Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
Danai Dima, Utkarsh Goel, Aishwarya Sannareddy, Nnaemeka Ibeh, Fauzia Ullah, Louis Williams

Hematol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy.
Danai Dima, Al-Ola Abdallah, James A Davis, Hussein Awada, Utkarsh Goel, Louis Williams

Blood Cancer J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study.
Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Louis Williams

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Palliative Care in the Supportive Management of AL Amyloidosis-A Review.
Muhammad Hamza Habib, Yun Kyoung Ryu Tiger, Danai Dima, Mathias Schlögl, Alexandra McDonald, Louis Williams

J Clin Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the GATMO score in predicting non-relapse mortality following hematopoietic cell transplant in multiple myeloma patients.
Hussein Awada, Adel Hajj Ali, Mohammad Zeineddine, Mohammad Rashid, Faiz Anwer, Louis Williams

Eur J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma.
Omar Nadeem, Sikander Ailawadhi, Jack Khouri, Louis Williams, Donna Catamero

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma.
Danai Dima, Mark Orland, Fauzia Ullah, Faiz Anwer, Sandra Mazzoni, Louis Williams

Clin Lymphoma Myeloma Leuk· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.
Eileen M Boyle, Patrick Blaney, James H Stoeckle, Yubao Wang, Hussein Ghamlouch, Louis Williams

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the CIBMTR scoring system in predicting early relapse of multiple myeloma after autologous hematopoietic cell transplant.
Hussein Awada, Ali Hajj Ali, Faiz Anwer, Craig Sauter, Louis Williams

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis